British Society for Immunology Congress 2017 | 4 - 7 December, Brighton UK

Yvette van Kooyk

VU University Medical Centre, Netherlands

Yvette van Kooyk is Professor of Molecular Cell Biology and Immunology and head of the department Molecular Cell Biology and Immunology at the VU University Medical Center in Amsterdam, the Netherlands. She leads a 20 member research team working on dendritic cell (DC) mediated immune responses guided by glycosylation. Her work is focussed on C-type lectin mediated innate immune responses and  cellular communication driven by modified glycoproteins/lipids in cancer and autoimmunity. Central in her work is the development of new glycan modified cancer vaccines targeting DC and the understanding of  glycan imposed regulatory immune imprinting by the tissue microenvironment. She was awarded an ERC-Advanced and the van Loghem award for life time achievements in field of Immunology. She is founder of the biotech company DC4U. She is a member of the Royal Netherlands Academy of Sciences (KNAW) and director of the Amsterdam Infection and Immunity research Institute AI&II